With sluggish pharmaceutical sales in the third quarter coming in below analysts’ expectations, Bayer is acutely aware of the challenges facing its key unit. | Despite the largely stagnant performance ...

One of the FDA’s potential approvals this month could break an existing monopoly in the treatment space for a rare growth ...

CytoSorbents Corporation , a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today reported financial results for the ...

Throughout history, humans have consumed some truly bizarre substances believing they would cure ailments or boost vitality.